ZARA, ERIKA
 Distribuzione geografica
Continente #
EU - Europa 198
NA - Nord America 149
AS - Asia 75
SA - Sud America 3
OC - Oceania 1
Totale 426
Nazione #
US - Stati Uniti d'America 144
IT - Italia 124
SG - Singapore 45
GB - Regno Unito 16
SE - Svezia 9
CH - Svizzera 7
CN - Cina 7
DE - Germania 7
IR - Iran 7
IN - India 6
KR - Corea 6
LT - Lituania 6
NL - Olanda 6
CA - Canada 5
ID - Indonesia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
FR - Francia 3
IE - Irlanda 3
RU - Federazione Russa 3
AR - Argentina 2
BG - Bulgaria 2
GR - Grecia 2
AT - Austria 1
AU - Australia 1
CL - Cile 1
FI - Finlandia 1
PL - Polonia 1
UA - Ucraina 1
Totale 426
Città #
Rome 56
Singapore 31
Santa Clara 22
Fairfield 15
Ashburn 11
Leeds 11
Houston 9
Woodbridge 6
Boardman 5
Princeton 5
San Diego 5
Toronto 5
Cambridge 4
Frankfurt am Main 4
Jakarta 4
Jinju 4
Millbury 4
Vilnius 4
Wilmington 4
Brussels 3
Campobasso 3
Dublin 3
Henrico 3
Lausanne 3
Lawrence 3
Prague 3
Seattle 3
Anacapri 2
Ann Arbor 2
Beijing 2
Buffalo 2
Cassino 2
Federal 2
Fiumicino 2
Foggia 2
Geneva 2
Genoa 2
Iglesias 2
Karystos 2
Milan 2
Moscow 2
Nagpur 2
New York 2
Nola 2
Oxford 2
Romainville 2
Siena 2
Sofia 2
Viterbo 2
Zurich 2
Bühl 1
Chicago 1
Florence 1
Hefei 1
Lappeenranta 1
Leawood 1
London 1
Los Angeles 1
Marseille 1
Melbourne 1
Mentana 1
Nuremberg 1
Palermo 1
Redwood City 1
San Paolo di Civitate 1
Torino 1
Utrecht 1
Vigonza 1
Warsaw 1
Totale 298
Nome #
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 123
Dominant {ARF}3 variants disrupt Golgi integrity and cause a neurodevelopmental disorder recapitulated in zebrafish 60
Functional characterization of novel germline mutations affecting CDC42 highlighted their differential impact on multiple signaling pathways. 54
Pro nerve growth factor and Its receptor p75NTR activate inflammatory responses in Synovial Fibroblasts: a novel targetable mechanism in Arthritis 43
Novel de novo CDC42 variants cause variable functional alterations and heterogeneous spectrum of neurodevelopmental and immune-hematologic rare diseases 37
Mutations at the C-terminus of CDC42 cause distinct post-translational modifications and hematopoietic and autoinflammatory disorders 36
Expanding the molecular spectrum of pathogenic SHOC2 variants underlying Mazzanti syndrome 30
Mutations at the C-terminus of CDC42 cause distinct hematopoietic and autoinflammatory disorders 28
De novo mutations involving the C-terminal tail of CDC42 cause distinct dyshematopoietic and autoinflammatory disorders 28
Functional variability of novel CDC42 pathogenic variants is associated with phenotypic heterogeneity of neurodevelopmental and immune-hematologic related disorders 25
Totale 464
Categoria #
all - tutte 2.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 0 0 37 9 5 2 2 0
2020/202124 4 1 0 3 1 2 0 3 2 2 6 0
2021/202254 0 0 3 2 4 2 1 3 25 1 7 6
2022/202368 8 5 1 0 8 21 4 7 5 3 4 2
2023/2024126 7 9 10 9 33 15 10 4 4 8 9 8
2024/2025121 5 14 24 23 24 27 4 0 0 0 0 0
Totale 464